Pfizer (Biologics Manufacturing Plant)
2009
FOUNDED
M&A
STATUS
Asset Purch.
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
133,000 square feet of floor space. The plant is built on ten acres occupying 133,000 square feet of floor space. The plant will be occupied in a phased transition with substantial manufacturing activities being tied to results of the ongoing Phase 3 clinical study for N-acetylgalactosamine 6-sulfatase for the treatment of Mucopolysaccharidosis IVA.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Acquirer
Primary Office
- Shanbally
- Ireland
Pfizer (Biologics Manufacturing Plant) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Pfizer (Biologics Manufacturing Plant)‘s full profile, request access.
Request full access to PitchBookPfizer (Biologics Manufacturing Plant) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Pfizer (Biologics Manufacturing Plant)‘s full profile, request access.
Request full access to PitchBook